Chacon R A, Corris P A, Dark J H, Gibson G J
Department of Respiratory Medicine, Freeman Hospital, Newcastle, upon Tyne, UK.
Thorax. 1998 Jan;53(1):43-9. doi: 10.1136/thx.53.1.43.
Single lung transplantation (SLT) is now a treatment option for patients with both pulmonary fibrosis and advanced chronic airway obstruction. Lung function after transplantation might be expected to be different in these two groups of patients because of the effect of the remaining native lung, but the implications of these differences have not been fully explored.
The functional results of a stable population of 20 patients (13 chronic airway obstruction, seven pulmonary fibrosis) after SLT with no evidence of obliterative bronchiolitis were analysed. The differences between the two populations in the interrelations between and determinants of total lung capacity (TLC), subdivisions of lung volume, airway function (spirometry, maximum expiratory flow volume curves, and moments analysis of the spirogram) respiratory mechanics (PV curves and maximal respiratory pressures), CO transfer factor (TLCO) and the distribution of perfusion, ventilation and volume of the transplanted and native lungs were compared.
Total lung capacity after SLT (TLCpost) was normal in the patients with pulmonary fibrosis (mean (SE) 103.9 (6.9)% predicted) but remained significantly elevated in patients with airway obstruction (126.4 (4.4)%. Forced expiratory volume in one second (FEV1) and vital capacity (VC) improved to similar values after SLT in both groups with a final VC of 76.8 (5.9)% and 66.7 (3.9)% in patients with fibrosis and airway obstruction, respectively. Maximum expiratory flows were generally lower and moments analysis of the spirogram showed slower lung emptying with significantly greater second and third moments (alpha 2 and alpha 3) in patients with airway obstruction. Relative ventilation and perfusion of the transplanted lung were both greater in both populations but relative ventilation of the transplanted lung was significantly greater in patients treated for airway disease than in those with pulmonary fibrosis. TLCO was also significantly higher in patients who had received a transplant for chronic airway obstruction.
These results suggest that differences in the functional results of SLT for airway disease and pulmonary fibrosis are relatively minor. In this series the native hyperinflated lung in chronic airway disease was not more disadvantageous to overall function than the native lung in pulmonary fibrosis. However, tests of lung function based on the terminal portion of the forced spirogram are likely to be less sensitive for the detection of obliterative bronchiolitis in patients who have received a transplant for advanced airway obstruction than in those with pulmonary fibrosis.
单肺移植(SLT)目前是治疗肺纤维化和晚期慢性气道阻塞患者的一种选择。由于剩余自体肺的影响,这两组患者移植后的肺功能可能会有所不同,但这些差异的影响尚未得到充分探讨。
分析了20例稳定的单肺移植患者(13例慢性气道阻塞,7例肺纤维化)的功能结果,这些患者均无闭塞性细支气管炎的证据。比较了两组患者在肺总量(TLC)、肺容积细分、气道功能(肺量计、最大呼气流量容积曲线和肺量图矩分析)、呼吸力学(压力-容积曲线和最大呼吸压力)、一氧化碳转运因子(TLCO)以及移植肺和自体肺的灌注、通气和容积分布之间的相互关系和决定因素的差异。
肺纤维化患者单肺移植后的肺总量(TLCpost)正常(平均(标准误)为预测值的103.9(6.9)%),而气道阻塞患者的肺总量仍显著升高(126.4(4.4)%)。两组患者单肺移植后一秒用力呼气容积(FEV1)和肺活量(VC)均改善至相似值,肺纤维化和气道阻塞患者的最终肺活量分别为预测值的76.8(5.9)%和66.7(3.9)%。气道阻塞患者的最大呼气流量通常较低,肺量图矩分析显示肺排空较慢,第二和第三矩(α2和α3)显著更大。两组患者移植肺的相对通气和灌注均较高,但气道疾病患者移植肺的相对通气显著高于肺纤维化患者。慢性气道阻塞患者移植后的TLCO也显著更高。
这些结果表明,气道疾病和肺纤维化单肺移植功能结果的差异相对较小。在本系列研究中,慢性气道疾病中过度膨胀的自体肺对整体功能的不利影响并不比肺纤维化中的自体肺更大。然而,基于用力肺量图终末部分的肺功能测试,在晚期气道阻塞患者移植后检测闭塞性细支气管炎时可能不如在肺纤维化患者中敏感。